These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Enhancement of Antigen Presentation by Deletion of Viral Immune Evasion Genes Prevents Lethal Cytomegalovirus Disease in Minor Histocompatibility Antigen-Mismatched Hematopoietic Cell Transplantation. Gezinir E; Podlech J; Gergely KM; Becker S; Reddehase MJ; Lemmermann NAW Front Cell Infect Microbiol; 2020; 10():279. PubMed ID: 32582572 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells. Ebert S; Böhm V; Büttner JK; Brune W; Brinkmann MM; Holtappels R; Reddehase MJ; Lemmermann NAW PLoS Pathog; 2024 Aug; 20(8):e1012173. PubMed ID: 39146364 [TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells. Hamdan S; Reddehase MJ; Holtappels R Med Microbiol Immunol; 2023 Apr; 212(2):153-163. PubMed ID: 35364731 [TBL] [Abstract][Full Text] [Related]
8. Antigen presentation under the influence of 'immune evasion' proteins and its modulation by interferon-gamma: implications for immunotherapy of cytomegalovirus infection with antiviral CD8 T cells. Fink A; Lemmermann NA; Gillert-Marien D; Thomas D; Freitag K; Böhm V; Wilhelmi V; Reifenberg K; Reddehase MJ; Holtappels R Med Microbiol Immunol; 2012 Nov; 201(4):513-25. PubMed ID: 22961126 [TBL] [Abstract][Full Text] [Related]
9. Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance. Holtappels R; Lemmermann NA; Podlech J; Ebert S; Reddehase MJ Front Immunol; 2016; 7():232. PubMed ID: 27379095 [TBL] [Abstract][Full Text] [Related]
10. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. Munks MW; Pinto AK; Doom CM; Hill AB J Immunol; 2007 Jun; 178(11):7235-41. PubMed ID: 17513772 [TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of cytomegalovirus infection by low-dose adoptive transfer of antiviral CD8 T cells relies on substantial post-transfer expansion of central memory cells but not effector-memory cells. Holtappels R; Becker S; Hamdan S; Freitag K; Podlech J; Lemmermann NA; Reddehase MJ PLoS Pathog; 2023 Nov; 19(11):e1011643. PubMed ID: 37972198 [TBL] [Abstract][Full Text] [Related]
12. Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool. Lemmermann NA; Reddehase MJ Med Microbiol Immunol; 2016 Dec; 205(6):549-561. PubMed ID: 27539576 [TBL] [Abstract][Full Text] [Related]
13. Mouse Model of Cytomegalovirus Disease and Immunotherapy in the Immunocompromised Host: Predictions for Medical Translation that Survived the "Test of Time". Reddehase MJ; Lemmermann NAW Viruses; 2018 Dec; 10(12):. PubMed ID: 30563202 [TBL] [Abstract][Full Text] [Related]
14. Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation. Reddehase MJ Front Immunol; 2016; 7():294. PubMed ID: 27540380 [TBL] [Abstract][Full Text] [Related]
15. Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax. La Rosa C; Longmate J; Lingaraju CR; Zhou Q; Kaltcheva T; Hardwick N; Aldoss I; Nakamura R; Diamond DJ Biol Blood Marrow Transplant; 2019 Apr; 25(4):771-784. PubMed ID: 30562587 [TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus misleads its host by priming of CD8 T cells specific for an epitope not presented in infected tissues. Holtappels R; Podlech J; Pahl-Seibert MF; Jülch M; Thomas D; Simon CO; Wagner M; Reddehase MJ J Exp Med; 2004 Jan; 199(1):131-6. PubMed ID: 14699084 [TBL] [Abstract][Full Text] [Related]
17. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation. Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296 [TBL] [Abstract][Full Text] [Related]